Related Experiment Video
Updated: Jun 30, 2026
08:58
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Understanding why probiotic therapies can be effective in treating IBD
1Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR), University of Alberta, Alberta, Edmonton, Canada. richard.fedorak@ualberta.ca
Journal of Clinical Gastroenterology
|October 1, 2008
Summary
Probiotics can reduce gastrointestinal inflammation by positively impacting epithelial cells and mucosal immune dysfunction, offering a therapeutic approach for inflammatory bowel disease (IBD). Further research into their mechanisms is ongoing.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- Probiotics are nonpathogenic bacteria with potential therapeutic benefits.
- Inflammatory bowel disease (IBD) involves complex intestinal inflammation.
- Understanding probiotic mechanisms is crucial for IBD treatment.
Purpose of the Study:
- To explore the mechanisms of action of probiotics in relation to IBD pathogenesis.
- To identify how probiotics influence intestinal health and immune responses.
Main Methods:
- Review of recent studies on probiotic mechanisms.
- Analysis of probiotic effects on epithelial cell function and immune modulation.
Main Results:
- Probiotics enhance epithelial barrier function and modulate cytokine secretion towards an anti-inflammatory profile.
- Probiotics alter mucus production, gut microbiota composition, and immune system responses, including regulatory T-cell induction.
- These effects directly impact intestinal health and reduce inflammation.
Conclusions:
- Probiotics demonstrate significant potential in reducing gastrointestinal inflammation.
- Their therapeutic role in IBD management is supported by their positive effects on epithelial and immune dysfunction.
- Alignment between probiotic mechanisms and IBD pathogenesis is key for effective clinical application.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:17Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...